Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05292846

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05292846
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy, Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05292846. Allocation not applicable; no masking; primary purpose prevention. Start 2022-01-20 (actual); primary completion 2024-02-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures
Acronym
DOAC-NOSTOP
Condition
Bleeding
Condition
Direct Acting Anticoagulant Adverse Reaction
Intervention (Drug)
Direct-acting oral anticoagulation
Lead sponsor
Hospital Universitario La Fe (class: other)

Record details

Record id
cardio:ct-nct05292846
Content hash
78cf7e02eee295d31e7b25782f98040fffbe39eebd58675df450ba136685d8d7